Valuation: Abbott Laboratories

Market Cap 20TCr 17TCr 16TCr 15TCr 28TCr 19,15700Cr 28TCr 1,90300Cr 74TCr 9,66500Cr 75TCr 74TCr 32,00800Cr P/E 2026 *
33.3x
P/E 2027 * 25.7x
Enterprise Value 22TCr 19TCr 18TCr 16TCr 31TCr 21,44000Cr 31TCr 2,13000Cr 83TCr 10,81700Cr 84TCr 83TCr 35,82200Cr EV / Sales 2026 *
4.47x
EV / Sales 2027 * 4.06x
Free-Float
86.16%
Yield 2026 *
2.21%
Yield 2027 * 2.36%
1 day-1.04%
1 week+0.73%
Current month+9.12%
1 month+9.40%
3 months+33.00%
6 months-0.20%
Current year-8.29%
1 week 112.5
Extreme 112.5
118
1 month 101.61
Extreme 101.61
118
Current year 82.05
Extreme 82.05
129.37
1 year 82.05
Extreme 82.05
137.44
3 years 82.05
Extreme 82.05
141.41
5 years 82.05
Extreme 82.05
142.15
10 years 38.23
Extreme 38.225978
142.15
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
-1.15%+0.73% - - 20TCr
-0.71%+1.02%-12.15%+12.46% 20TCr
+0.68%-2.68%-0.62%+12.56% 12TCr
+0.35%+3.52%+13.31%+81.98% 6.26TCr
-0.12%-1.77%+29.62%+56.62% 5.25TCr
+0.63%+1.43%-1.95%-32.42% 5.17TCr
-0.10%-1.30%+16.54%-10.66% 3.36TCr
-1.22%+4.90% - - 3.13TCr
+0.71%-1.13%+42.66%-13.53% 2.45TCr
-0.94%+4.05%-2.80%+19.77% 2.4TCr
Average -0.15%+1.39%+10.58%+15.85% 6.64TCr
Weighted average by Cap. -0.30%+1.53%+2.31%+17.97%

Financials

2026 *2027 *
Net sales 5.03TCr 4.31TCr 4.04TCr 3.69TCr 6.96TCr 4,79600Cr 7.03TCr 48TCr 19TCr 2,41900Cr 19TCr 18TCr 8,01200Cr 5.46TCr 4.68TCr 4.39TCr 4.01TCr 7.56TCr 5,21000Cr 7.64TCr 52TCr 20TCr 2,62800Cr 21TCr 20TCr 8,70400Cr
Net income 623.24Cr 534.05Cr 500.42Cr 457.1Cr 862.65Cr 59TCr 871.16Cr 5.9TCr 2.3TCr 30TCr 2.34TCr 2.29TCr 99TCr 792.44Cr 679.04Cr 636.28Cr 581.2Cr 1.1TCr 76TCr 1.11TCr 7.51TCr 2.92TCr 38TCr 2.98TCr 2.91TCr 1,26200Cr
Net Debt 2.39TCr 2.05TCr 1.92TCr 1.76TCr 3.31TCr 2,28200Cr 3.35TCr 23TCr 8.83TCr 1,15100Cr 8.99TCr 8.79TCr 3,81300Cr 2.1TCr 1.8TCr 1.68TCr 1.54TCr 2.9TCr 1,99800Cr 2.93TCr 20TCr 7.73TCr 1,00800Cr 7.87TCr 7.7TCr 3,33800Cr
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
1,15,000
Date Price Change Volume
26/26/26 $115.38 -1.09% 565
25/26/25 $115.83 -0.75% 17,356
24/26/24 $116.70 +0.25% 6,680
21/26/21 $116.41 +1.48% 3,575
20/26/20 $114.71 +0.15% 10,584
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
116.13USD
Average target price
120.20USD
Spread / Average Target
+3.50%

Quarterly revenue - Rate of surprise